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ABSTRACT 15 
In an attempt to understand the structural characteristics of phenolic compounds that 16 
favor the inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) 17 
formation, this study analyzes the role of twenty-five phenolic compounds on the PhIP 18 
produced in phenylalanine/creatinine/oxidized lipid reaction mixtures. The obtained 19 
results showed that phenols having two hydroxy groups at meta positions of the 20 
aromatic ring were the most efficient inhibitors. The presence of alkyl or carboxylic 21 
groups as additional substituents in the aromatic ring slightly reduced the inhibitory 22 
effect. On the other hand, the introduction of additional hydroxy and amino groups 23 
mostly cancelled the inhibitory effect, which was also mostly absent in ortho and para 24 
dihydroxy derivatives. In complex phenols, the presence of several rings with opposite 25 
effects produced a reduced inhibitory effect. All these results suggest that it is possible 26 
to predict if a phenolic derivative will inhibit the formation of PhIP, or not, based on its 27 
structure. 28 
 29 
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1. Introduction 33 
 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is one of the most 34 
abundant heterocyclic aromatic amines (HAAs) formed during thermal processing of 35 
proteinaceous foods such as cooked beef, pork, chicken, and fish (Skog, Johansson, & 36 
Jägerstad, 1998). This HAA produces colon, prostate, and mammary gland tumors in 37 
rodents (Alaejos, Pino, & Afonso, 2008; Cheung, Loy, Li, Liu, & Yang, 2011; 38 
Choudhary, Sood, Donnell, & Wang, 2012), and the International Agency for Research 39 
on Cancer (IARC) has concluded that there is sufficient evidence in experimental 40 
animals for PhIP carcinogenicity (IARC, 1993). In addition, this compound is also 41 
considered as possibly carcinogenic to humans (IARC, 1993). 42 
At present, PhIP is believed to be mainly produced from phenylalanine, creati(ni)ne 43 
and carbohydrates as a by-product of the Maillard Reaction (Shioya, Wakabayashi, 44 
Sato, Nagao, & Sugimura, 1987). The reaction takes place in several steps, among 45 
which the formation of phenylacetaldehyde by phenylalanine degradation and the later 46 
reaction of the produced phenylacetaldehyde with creati(ni)ne seem to be key steps 47 
(Murkovic, Weber, Geiszler, Fröhlich, & Pfannhauser, 1999). Because conversion of 48 
phenylalanine into phenylacetaldehyde is not only produced by carbohydrates, but also 49 
by other reactive carbonyls such as those formed in the course of lipid oxidation 50 
(Hidalgo & Zamora, 2004), recent studies have shown that oxidized lipids are also able 51 
to contribute to PhIP formation (Zamora, Alcon, & Hidalgo, 2012; 2013a). 52 
Furthermore, the carbonyl compounds produced by thermal decomposition of some 53 
amino acids also contribute to PhIP formation (Zamora, Alcon, & Hidalgo, 2013b). 54 
Inhibition of PhIP formation has been the objective of numerous studies, and many 55 
authors have shown that the use of phenolic compounds and plants extracts rich in them 56 
decreases the PhIP formed (see, for example, Damasius, Venskutonis, Ferracane, & 57 
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Fogliano, 2011; Gibis, & Weiss, 2012; Janoszka, 2010; Murkovic, Steinberger, & 58 
Pfannhauser, 1998; Quelhas, Petisca, Viegas, Melo, Pinho, & Ferreira, 2010). However, 59 
the inhibition of PhIP formation has not been well correlated to the antioxidant/free 60 
radical scavenging capacity of phenolic compounds and spice extracts (Cheng, Chen, & 61 
Wang, 2007; Damasius, Venskutonis, Ferracane, & Fogliano, 2011), which has 62 
suggested that an antioxidant-independent mechanism should be playing a role in the 63 
inhibition of PhIP by phenolic compounds. 64 
In an attempt to understand the structural characteristics of phenolic compounds that 65 
favor the inhibition of PhIP formation, this study analyzes the role of twenty-five 66 
phenolic compounds on the PhIP produced in phenylalanine/creatinine/oxidized lipid 67 
reaction mixtures. This model system was selected because it is an efficient PhIP 68 
producer (Zamora, Alcon, & Hidalgo, 2012; 2013a). 69 
2. Materials and methods 70 
2.1. Materials 71 
Twenty-five phenolic compounds were employed in this study. They are collected in 72 
Fig. 1. As can be observed, most of them were simple compounds having two or three 73 
hydroxy groups at different positions of the benzene ring. In addition, alkyl, methoxy, 74 
amino, and carboxylic groups were also present in some derivatives. Furthermore, some 75 
complex phenolic compounds having more than one aromatic ring with hydroxy groups 76 
were also studied for comparison purposes. To facilitate the study of the assayed 77 
phenols, these compounds have been classified into five groups: o-dihydroxy 78 
derivatives and analogs, m-dihydroxy derivatives and analogs, p-dihydroxy derivatives 79 
and analogs, trihydroxy derivatives, and complex phenols. All these compounds were 80 
purchased from commercial sources (see below). 81 
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2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) was purchased from 82 
Toronto Research Chemicals (North York, Ontario, Canada). 4-Oxo-2-nonenal was 83 
prepared from 2-pentylfuran according to Shimozu, Shibata, Ojika, & Uchida (2009). 84 
All other chemicals were purchased from Aldrich (Milwakee, WI, USA), Sigma (St. 85 
Louis, MO, USA), Fluka (Buchs, Switzerland), or Merck (Darmstadt, Germany), and 86 
were analytical grade. 87 
2.2. PhIP formation in phenylalanine/creatinine/oxidized lipid/phenolic compound 88 
reaction mixtures 89 
A mixture of creatinine (10 mol), phenylalanine (10 mol), and the lipid-derived 90 
reactive carbonyl (10 mol) in 500 L of 0.3 M sodium phosphate, pH 8, was treated, 91 
or not (control), with the phenolic compound (0–10 mol), and heated at 200 ˚C in 92 
closed test tubes for 1 h. Three different lipid-derived reactive carbonyls were employed 93 
to investigate the effect of the type of lipid on the mitigation of PhIP formation 94 
produced by phenolic compounds. These oxidized lipids were: 2-octenal, 2,4-95 
decadienal, and 4-oxo-2-nonenal. 96 
After cooling (20 min at room temperature), 100 L of the reaction mixture was 97 
diluted with 50 L of internal standard (IS) solution (1.29 mg of caffeine in 5 mL of a 98 
30:70 mixture of 0.2% formic acid in acetonitrile and 4 mM ammonium acetate), and 99 
850 L of a 30:70 mixture of 0.2% formic acid in acetonitrile and 4 mM ammonium 100 
acetate. PhIP content was determined by LC–MS/MS. 101 
2.3. PhIP determination by LC–MS/MS 102 
Samples were analyzed using an Agilent liquid chromatography system (1200 103 
Series) consisting of binary pump (G1312A), degasser (G1379B), and autosampler 104 
(G1329A), connected to a triple quadrupole API 2000 mass spectrometer (Applied 105 
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Biosystems) using an electrospray ionization interface in positive ionization mode 106 
(ESI+). Compounds were separated on a Zorbax Eclipse XDB-C18 (150 mm x 4.6 mm, 107 
5 m) column from Agilent. As eluent, a 30:70 mixture of 0.2% formic acid in 108 
acetonitrile and 4 mM ammonium acetate was used. The mobile phase was delivered at 109 
0.5 mL/min in isocratic mode. Mass spectrometric acquisition was performed by using 110 
multiple reaction monitoring (MRM). The nebulizer gas (synthetic air), the curtain gas 111 
(nitrogen), and the heater gas (synthetic air) were set at 45, 25, and 50 (arbitrary units), 112 
respectively. The collision gas (nitrogen) was set at 5 (arbitrary units). The heater gas 113 
temperature was set at 500 ºC and the electrospray capillary voltage to 5.5 kV. The 114 
fragment ions in MRM mode were produced by collision-activated dissociation of 115 
selected precursor ions in the collision cell of the triple quadrupole and analyzed the 116 
selected products with the second analyzer of the instrument. Three transitions were 117 
acquired for the identification of both PhIP and the IS. To establish the appropriate 118 
MRM conditions for the individual compounds, the mass spectrometric conditions were 119 
optimized by using infusion with a syringe pump to select the most suitable ion 120 
transitions for the target analytes. Precursor and product ions used for confirmation 121 
purposes and operating conditions were described previously (Zamora, Alcon, & 122 
Hidalgo, 2012). The 225.0 → 210.1 and 195.2 → 138.0 transitions for PhIP and 123 
caffeine, respectively, were used for quantification purposes in this study. 124 
2.4. PhIP quantification 125 
Quantification of PhIP was carried out by preparing five standard curves of this 126 
compound in 500 L of 0.3 M sodium phosphate buffer, pH 8.0, and following the 127 
whole procedure described above. For each curve, seven different concentration levels 128 
of PhIP (0–2 nmol) were used. PhIP content was directly proportional to the PhIP/IS 129 
area ratio (r > 0.997, p < 0.0001). The limit of detection (LOD), defined as the lowest 130 
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sample concentration that could be detected with a signal-to-noise ratio (S/N) greater 131 
than three (Hidalgo, Alaiz, & Zamora, 2001), was 0.005 nmol. The limit of quantitation 132 
(LOQ), defined as the lowest concentration that could be quantitated with a precision 133 
less than 15%, was 0.01 nmol. 134 
2.5. Formation of phenylacetaldehyde in phenylalanine/oxidized lipid/phenolic 135 
compound reaction mixtures 136 
Mixtures of phenylalanine (10 mol), a lipid-derived reactive carbonyl (10 µmol), 137 
and the phenolic compound (0–10 mol) in 500 L of 0.3 M sodium phosphate, pH 8, 138 
were heated in closed test tubes at 200 ºC for 1 h. The assayed phenolic compounds 139 
were 1,2-dihydroxybenzene, resorcinol, and 1,4-dihydroxybenzene as model o-, m-, and 140 
p-dihydroxy derivatives, respectively. The lipid-derived reactive carbonyls employed 141 
were: 2-octenal, 2,4-decadienal, and 4-oxo-2-nonenal. After cooling (20 min at room 142 
temperature), reaction mixtures were diluted with 1 mL of acetonitrile, 50 L of internal 143 
standard solution (54.8 mg of methyl heptanoate in 25 mL of ethanol) was added, and 144 
samples were analyzed by GC-MS. 145 
2.6. GC-MS analyses 146 
GC-MS analyses were conducted with a Hewlett-Packard 6890 GC Plus coupled 147 
with an Agilent 5973 MSD (mass selective detector, quadrupole type). A fused-silica 148 
HP5-MS capillary column (30 m × 0.25 i.d.; coating thickness, 0.25 μm) was used, and 149 
1 μL of sample was injected in the pulsed splitless mode. Working conditions were as 150 
follows: carrier gas, helium (1 mL/min at constant flow); injector, 250 °C; oven 151 
temperature programmed from 40 °C (1 min) to 240 °C at 5 °C/min and then to 300 °C 152 
at 10 °C/min; transfer line to MSD, 280 °C; ionization EI, 70 eV; ion source 153 
temperature, 230 °C; and mass range 28−550 amu. 154 
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2.7. Determination phenylacetaldehyde content 155 
Quantification of phenylacetaldehyde was carried out, as described previously 156 
(Zamora, Gallardo, & Hidalgo, 2007), by preparing standard curves of the aldehyde in 157 
the 1.55 mL of solution prepared for GC-MS injection. For each curve, eight different 158 
concentration levels of the aldehyde were used. Phenylacetaldehyde content was 159 
directly proportional to the aldehyde/internal standard area ratio (r = 0.999, p < 0.0001). 160 
The coefficients of variation were <10%. 161 
2.8. Statistical analysis 162 
All data given are mean or mean ± SD values of, at least, three independent 163 
experiments. Statistical comparisons among different groups were made using analysis 164 
of variance. When significant F values were obtained, group differences were evaluated 165 
by the Tukey test (Snedecor & Cochran, 1980). Median effective concentration (EC50) 166 
values, which are the concentrations of the phenolic compounds needed to reduce a 50 167 
% the PhIP formed, were obtained from the best-fit line plotting concentration of 168 
phenolic compound versus PhIP levels. Statistical comparisons and nonlinear curve 169 
fitting for EC50 determination were carried out using Origin® v.8.0724 (OriginLab 170 
Corporation, Northampton, MA). The significance level is p < 0.05 unless otherwise 171 
indicated. 172 
3. Results 173 
3.1. PhIP mitigation produced by o-dihydroxy derivatives and analogs in 174 
phenylalanine/creatinine/oxidized lipid reaction mixtures. 175 
The curves obtained for PhIP formation as a function of the concentration of the 176 
phenolic compound having the two hydroxy groups (or one hydroxy and one methoxy 177 
group) at ortho positions of the aromatic ring are shown in Fig. 2A. These curves were 178 
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similar independently of the lipid involved. As observed in the figure for the 1,2-179 
dihydroxybenzene, the amount of PhIP increased when the phenol was added in the 180 
range 0-1 µmol, and decreased afterwards, although this decrease was not very sharp in 181 
most cases. For that reason, the EC50 was high in all derivatives assayed (Table 1). 182 
Thus, the most simple derivative (1,2-dihydroxybenzene) had a mean EC50 of 7.57 183 
µmol. The introduction of a carboxylic group (3,4-dihydroxybenzoic acid) decreased 184 
the effectiveness of the phenolic compound and a mean EC50 >12 µmol was obtained. 185 
When the carboxylic group was separated from the aromatic ring by a carbon-carbon 186 
double bond and one of the hydroxy groups was substituted by a methoxy group (ferulic 187 
acid), the effectiveness of the phenolic compound for PhIP inhibition improved but 188 
EC50 was still very high (mean EC50 >10 µmol). 189 
3.2. PhIP mitigation produced by m-dihydroxy derivatives and analogs in 190 
phenylalanine/creatinine/oxidized lipid reaction mixtures. 191 
The curves obtained for PhIP formation as a function of the concentration of the 192 
phenolic compound having the two hydroxy (or analogue) groups at meta positions of 193 
the aromatic ring are shown in Fig. 2B. These curves were always similar and 194 
independent of the lipid involved. As observed in the figure for the resorcinol, the 195 
amount of the produced PhIP decreased exponentially when the concentration of the 196 
phenolic compound increased. This rapid decrease of the PhIP produced low mean 197 
EC50 values for most m-dihydroxy derivatives assayed (Table 1). Thus, the simplest 198 
derivative (resorcinol) had a mean EC50 of 1.31 µmol and was the most efficient PhIP 199 
inhibitor among the assayed in this study. The introduction of a methyl group in the 200 
aromatic ring increased slightly the mean EC50 and this increase depended on the 201 
position and the number of methyl groups. Thus, the introduction of the methyl group at 202 
the position 2 (2-methylresorcinol) increased the mean EC50 to 1.97 µmol. This value 203 
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was very similar to the obtained when the methyl group was introduced at position 5 204 
(orcinol). The mean EC50 was 2.10 µmol for this last compound. When two methyl 205 
groups were present at positions 2 and 5 (2,5-dimethylresorcinol), the mean EC50 206 
obtained was 2.67 µmol. The introduction of a carboxylic group (2,6-dihydroxybenzoic 207 
acid) increased more the mean EC50. The obtained value was 2.92 µmol. Differently to 208 
methyl and carboxylic groups, the introduction of an amino group mostly destroyed the 209 
inhibitory effect of resorcinol and the mean EC50 obtained was 8.02 µmol for 2-210 
aminoresorcinol, similar to 1,2-dihydroxybenzene. 211 
The presence of two hydroxy groups at meta positions are not needed for the 212 
observed effect. In fact, when one hydroxy group was substituted by a methoxy group 213 
(3-methoxyphenol), the mean EC50 obtained (2.10 µmol) was higher than the obtained 214 
for resorcinol (1.02 µmol), but 3-methoxyphenol was still a very efficient PhIP 215 
inhibitor. However, this methoxy group cannot be substituted by a dimethylamino group 216 
[3-(dimethylamino)phenol], because the obtained phenol does not inhibit PhIP 217 
formation (mean EC50 >12 µmol). Furthermore, the presence of at least one hydroxy 218 
group is necessary to observe inhibition. Thus, the mean EC50 for 1,3-dimethoxyphenol 219 
was >12 µmol. 220 
3.3. PhIP mitigation produced by p-dihydroxy derivatives and analogs in 221 
phenylalanine/creatinine/oxidized lipid reaction mixtures. 222 
The curves obtained for PhIP formation as a function of the concentration of the 223 
phenolic compound having the two hydroxy groups (or one hydroxy and one methoxy 224 
group) at para positions of the aromatic ring are shown in Fig. 2C. These curves were 225 
independent of the lipid involved and were very similar to that obtained for o-dihydroxy 226 
derivatives and analogs. As observed in the figure for the 1,4-dihydroxybenzene, the 227 
amount of PhIP increased when the lipid was added in the range 0-1 µmol, and 228 
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decreased afterwards, although this decrease was not very rapid for most compounds. 229 
For that reason, the EC50 was high in all derivatives assayed (Table 1). In fact, the 230 
inhibitory capacity of 1,4-dihydroxybenzene (mean EC50 = 9.74 µmol) was worse than 231 
the inhibitory capacity of 1,2-dihydroxybenzene (mean EC50 = 7.57 µmol). However, 232 
when its oxidized derivative was studied (benzoquinone), this compound was more 233 
efficient (mean EC50 = 6.91 µmol) than the corresponding p-dihydroxy derivative 234 
(mean EC50 = 9.74 µmol). Introduction of methyl groups (trimethylhydroquinone), one 235 
carboxylic group (2,5-dihydroxybenzoic acid), or the substitution of one hydroxy group 236 
by a methoxy group (4-methoxyphenol), produced derivatives that did not exhibit PhIP 237 
inhibitory effect (EC50 >12 µmol). 238 
3.4. PhIP mitigation produced by trihydroxy derivatives in 239 
phenylalanine/creatinine/oxidized lipid reaction mixtures. 240 
Trihydroxy derivatives assayed did not show a homogeneous behavior (Table 1). 241 
Thus, pyrogallol had mean EC50 of 9.66 µmol. This value was even higher than that 242 
obtained by the analogous compound 2-aminoresorcinol in which the central hydroxy 243 
group was substituted by an amino group. The introduction of a carboxylic group in the 244 
ring slightly improved the PhIP inhibitory effect but the resulting phenolic compound 245 
(gallic acid) was still a poor inhibitor (mean EC50 = 8.98 µmol). 246 
When the three hydroxy groups were not grouped, the PhIP inhibitory effect 247 
improved. Thus, 1,2,4-trihydroxybenzene had a mean EC50 of 8.20 µmol and 248 
phloroglucinol had a mean EC50 of 3.62 µmol. This last inhibitory effect was worse 249 
than the observed for resorcinol (1.02 µmol) in spite of having its three hydroxyl groups 250 
at meta position from each other. 251 
3.5. PhIP mitigation produced by complex phenols in phenylalanine/creatinine/oxidized 252 
lipid reaction mixtures. 253 
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Resveratrol has two hydroxy groups in meta position at the A-ring and one hydroxy 254 
group at the B-ring. It is likely that this configuration contributed to this high PhIP 255 
inhibitory effect (mean EC50 = 1.37 µmol, Table 1). 256 
Quercetin has also two hydroxy groups in meta position at the A-ring, but it has also 257 
two hydroxy groups in ortho position at the B-ring. In addition, it has a conjugated 258 
carbonyl and an hydroxy group at the C-ring. This configuration resulted in a worse 259 
inhibitory effect of this compound for PhIP formation (mean EC50 = 3.08 µmol) than 260 
the inhibitory effect exhibited by resveratrol (mean EC50 = 1.37 µmol). 261 
Configuration of epicatechin and catechin was analogous to that of quercentin in 262 
rings A and B, but they did not have the conjugated carbonyl group at the C-ring. This 263 
change decreased the inhibitory power for PhIP formation of epicathechin and catechin 264 
in comparison to that of quercetin. In addition, catechin resulted a better inhibitor (mean 265 
EC50 = 3.89 µmol) than epicathechin (mean EC50 = 6.35 µmol) in spite of the 266 
similarity among their structures that only differ in the configuration of carbon 2. 267 
3.6. Formation of phenylacetaldehyde in phenylalanine/oxidized lipid/phenolic 268 
compound reaction mixtures 269 
Phenolic compounds can play a role in PhIP formation either by modification of the 270 
conversion of phenylalanine into phenylacetaldehyde or by playing a role in the reaction 271 
between phenylacetaldehyde and creatinite to produce PhIP. To determine the role of 272 
phenolic compounds in the first step of the reaction, these compounds, together with 273 
phenylalanine and the oxidized lipids were heated and the amount of 274 
phenylacetaldehyde formed was determined. Creatinine was not added to the reaction 275 
mixture to avoid the disappearance of the formed phenylacetaldehyde. The obtained 276 
results for 1,2-dihydroxybenzene, resorcinol, and 1,4-dihydroxybenzene, as model o-, 277 
m-, and p-dihydroxy derivatives, respectively, are shown in Fig. 3. As can be observed, 278 
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and differently to PhIP formation, all assayed phenolic compounds decreased 279 
exponentially the amount of phenylacetaldehyde produced when the amount of the 280 
phenolic compound increased.  281 
4. Discussion 282 
 Many studies have analyzed the antioxidant capacity of phenolic compounds, 283 
concluding that it is strongly related to the number and position of their hydroxy groups 284 
as well as their aromatic structure (Rigo et al., 2000). The results obtained in this study 285 
suggest that this conclusion is also valid for the inhibition of PhIP formation, although 286 
the structural characteristics that promote antioxidative properties do not seem to be the 287 
same as that those that favor the inhibition of PhIP formation. Thus, PhIP formation 288 
seems to be mainly inhibited by phenolic compounds having two hydroxy groups at 289 
meta positions in the aromatic ring. For that reason, resorcinol, its derivatives having 290 
methyl, methoxy, or carboxylic groups as additional substituents in the aromatic ring, 291 
and resveratrol were the best inhibitors for PhIP formation found in this study. The 292 
introduction of hydroxy, amino, or alkylamino groups at the aromatic ring decreased 293 
significantly the PhIP inhibitory potential of the phenolic compounds, most likely as a 294 
consequence of the electronic effects of these groups. If these groups are introduced at 295 
ortho or para positions in relation to the other two hydroxy groups, the PhIP inhibitory 296 
activity is much reduced such as in pyrogallol and 1,2,4-trihydroxybenzene. Only when 297 
the new group is introduced at the meta position in relation to the other two hydroxy 298 
groups, as occurs in phloroglucinol, the inhibitory activity is lower than the exhibited by 299 
resorcinol but the resulting phenol is still a good inhibitor of PhIP formation. The same 300 
occurs when the phenol has more than one ring with opposing effects, such as in 301 
quercetin, catechin and epicatechin. On one hand, the resorcinol-like A-ring present in 302 
these complex phenols promotes the PhIP inhibitory effect. On the other, the B-ring 303 
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containing two hydroxy groups at ortho positions reduces the inhibitory effect of the A-304 
ring. Nevertheless, although reduced with respect to resorcinol and its simple 305 
derivatives, the assayed complex phenols still exhibited a significant PhIP inhibitory 306 
effect. For that reason, many studies have shown that black and green tea as well as 307 
wine marinades efficiently reduce PhIP formation in both foods and model systems 308 
(see, for example, Busquets, Puignou, Galcerán & Skog, 2006; Quelhas, Petisca, 309 
Viegas, Melo, & Ferreira, 2010; Melo, Viegas, Petisa & Ferreira, 2008; Weisburger, 310 
Nagao, Wakabayashi, & Oguri,1994). 311 
The mechanism by which resorcinol-like phenols inhibit PhIP formation is unclear at 312 
present and should be further investigated. Nevertheless, the results obtained by 313 
studying the effect of phenols in phenylacetaldehyde formation showed that the assayed 314 
o-, m-, and p-dihydroxy derivatives decreased phenylacetaldehyde formation, which 315 
might be a consequence of either the reaction between phenylacetaldehyde and phenolic 316 
compounds shown by Cheng, Wong, Cho, Chu, Sze, Lo, Chen, & Wang (2008), or 317 
between the phenolic compounds and the carbonyl compounds that promote 318 
phenylalanine degradation. However, to explain the behavior observed for PhIP 319 
formation in the presence of o- and p-dihydroxy derivatives, these compounds should 320 
promote the reaction of phenylacetaldehyde with creatinine. This would explain the 321 
curve obtained in Fig. 2 for ortho and para derivarives. Thus, at low phenol 322 
concentration, phenylacetaldehyde formation is only slightly reduced and the promoted 323 
reaction between phenylacetaldehyde and creatinine should produce more PhIP. When 324 
the amount of phenolic compound increased, the formation of phenylacetaldehyde was 325 
so inhibited that PhIP was decreased also for ortho and para derivatives. On the 326 
contrary, meta dihydroxy derivatives should not influence the reaction between 327 
phenylacetaldehyde and creatinine, and a correlation (r > 0.973, p < 0.0001) between 328 
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the effect of these phenolic compounds on phenylacetaldehyde disappearance and PhIP 329 
formation was observed. The reason by which ortho and para dihydroxy derivatives 330 
seem to promote the formation of PhIP at low concentration of o- and p-dihydroxy 331 
derivatives will be the objective of future investigations. 332 
The results obtained in this study provide the basis to understand the role of phenolic 333 
compounds in PhIP formation and suggest that it is possible to predict if a phenolic 334 
derivative will inhibit or not the formation of PhIP based on its structure. Although the 335 
validity of these conclusions should be further confirmed in real foods, the above results 336 
suggest that to decrease PhIP formation, the use of meta dihydroxy derivatives should 337 
be employed. Thus, the use of meta dihydroxy derivatives in marinating and meat 338 
processing industries may be an attractive way for adding value to these products in 339 
terms of minimizing the risk of exposure to PhIP and to improve nutritional 340 
characteristics of foods in which antioxidants may be used in their formulation. 341 
Nevertheless, this conclusion is only valid for PhIP and not for other HAAs that are 342 
produced by other reaction pathways. Therefore, additional studies are needed to 343 
investigate the role, if any, of meta dihydroxy derivatives on the formation of other 344 
HAAs. A different role of phenolic compounds on the formation of the several HAAs 345 
might be expected because the several HAAs are produced by different pathways. 346 
Therefore, the use of a specific phenolic derivative might decrease one HAA and either 347 
not produce any result or even increase the formation of other HAAs, as it have been 348 
observed in many studies (see, for example, Damasius, Venskutonis, Ferracane, & 349 
Fogliano, 2011).  350 
Abbreviations used 351 
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EC50, median effective concentration; HAAs, heterocyclic aromatic amines; IARC, 352 
International Agency for Research on Cancer; PhIP, 2-amino-1-methyl-6-353 
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Table 1 
EC50 values determined for phenolic compounds in phenylalanine/creatinine/oxidized 
lipid reaction mixtures 
  Oxidized lipid  
Compound 2-Octenal 2,4-Decadienal 4-Oxo-2-nonenal Mean EC50
o-dihydroxy derivatives and analogs 
1,2 Dihydroxybenzene 8.22 ± 0.98 f,g,h 8.55 ± 1.59 c,d,e 5.93 ± 1.21 c,d 7.57 
3,4-Dihydroxybenzoic acid > 12 > 12 > 12  > 12 
Ferulic acid 11.22 ± 1.05 i > 12 7.87± 0.36  d,e > 10 
m-dihydroxy derivatives and analogs 
Resorcinol 1.09 ± 0.37 a 1.82 ± 0.38 a,b 1.02 ± 0.26 a 1.31 
2-Methylresorcinol 2.62 ± 0.52 a,b,c 1.19 ± 0.14 a 2.09 ± 0.66 a,b 1.97 
Orcinol 1.98 ± 0.66 a,b 2.53 ± 0.98 a,b 1.80 ± 0.20 a 2.10 
2,5-Dimethylresorcinol 2.77 ± 0.89 a,b,c 2.62 ± 0.99 a,b 2.63 ± 0.79 a,b 2.67 
2-Aminoresorcinol 7.72 ± 0.36 f,g,h 8.83 ± 1.03 c,d,e 7.50 ± 1.49 d,e 8.02 
2,6-Dihydroxybenzoic acid 3.03 ± 0.10 a,b,c 4.31 ± 1.43 b 1.42 ± 0.73 a 2.92 
3-Methoxyphenol  1.08 ± 0.60 a 3.61 ± 0.83 a,b 1.62 ± 0.38 a 2.10 
3-(Dimethylamino)phenol > 12  > 12 > 12  > 12 
1,3-Dimethoxybenzene > 12   > 12 > 12   > 12 
p-dihydroxy derivatives and analogs 
1,4-Dihydroxybenzene 11.50 ± 2.39 i 10.96 ± 0.60 e 6.77 ± 1.48 d,e 9.74 
1,4-Benzoquinone 6.79 ± 0.39 e,f,g 7.72 ± 0.67 c 6.26 ± 0.60 c,d,e 6.91 
Trimethylhydroquinone > 12  > 12  > 12  > 12 
2,5-Dihydroxybenzoic acid > 12  > 12  > 12  > 12 
4-Methoxyphenol > 12  > 12  > 12  > 12 
trihydroxy derivatives 
Pyrogallol 9.51 ± 1.24 h,i 10.50 ± 0.74 d,e 8.97 ± 1.23 e 9.66 
1,2,4-Trihydroxybenzene 9.38 ± 0.61 g,h,i 9.18 ± 0.55 c,d,e 6.05 ± 0.95 c,d,e 8.20 
Phloroglucinol 3.95 ± 0.03 b,c,d 4.19 ± 0.40 b 2.72 ± 1.00 a,b 3.62 
Gallic acid 11.26 ± 0.53 i 8.18 ± 1.02 c,d 7.49 ± 0.84 d,e 8.98 
complex phenols 
Resveratrol 1.41 ± 0.34 a,b 1.25 ± 0.66 a 1.46 ± 0.61 a 1.37 
Quercetin 2.69 ± 0.84 a,b,c 3.69 ± 0.62 a,b 2.87 ± 0.32 a,b 3.08 
(+)-Catechin  4.91 ± 1.23 c,d,e 3.33 ± 0.76 a,b 3.44 ± 0.14 a,b,c 3.89 
(-)-Epicatechin 6.56 ± 0.71 d,e,f 7.56 ± 1.22 c 4.92 ± 0.64 b,c,d 6.35 
Values are mean ± SD (in µmol) for, at least, three independent experiments. Means in 
the same column with different superscripts are significantly different (p < 0.05). 
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Figure legends 
Fig. 1. Chemical structures of the phenolic compounds employed in this study. They 
have been classified according to the number and position of hydroxy groups in the 
benzene ring. 
Fig. 2. Effect of the concentration of the phenolic compound on the PhIP produced in 
phenylalanine/creatinine/oxidized lipid mixtures heated for 1 h at 200 ºC. The phenolic 
compounds assayed were: A, 1,2-dihydroxybenzene; B, resorcinol; and C, 1,4-
dimethylbenzene. The oxidized lipids assayed were: 2-octenal (), 2,4-decadienal (), 
and 4-oxo-2-nonenal ().  
Fig. 3. Effect of the concentration of the phenolic compound on the phenylacetaldehyde 
produced in phenylalanine/oxidized lipid mixtures heated for 1 h at 200 ºC. The 
phenolic compounds assayed were: A, 1,2-dihydroxybenzene; B, resorcinol; and C, 1,4-
dimethylbenzene. The oxidized lipids assayed were: 2-octenal (), 2,4-decadienal (), 
and 4-oxo-2-nonenal (). 
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